| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
55,842 |
49,320 |
$3.44M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
31,374 |
28,272 |
$1.42M |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
4,572 |
880 |
$885K |
| 99215 |
Prolong outpt/office vis |
1,930 |
1,795 |
$166K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,667 |
1,635 |
$144K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,378 |
1,354 |
$116K |
| 95144 |
|
766 |
206 |
$91K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,256 |
5,398 |
$83K |
| 92551 |
|
7,359 |
7,071 |
$64K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,181 |
2,066 |
$42K |
| 93000 |
|
3,138 |
3,017 |
$32K |
| 99385 |
|
310 |
301 |
$30K |
| 90688 |
|
2,146 |
1,830 |
$23K |
| 81002 |
|
9,380 |
8,707 |
$22K |
| 82962 |
|
10,480 |
9,051 |
$18K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,354 |
2,249 |
$17K |
| 80305 |
|
2,295 |
2,127 |
$17K |
| 99397 |
|
454 |
428 |
$16K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
97 |
94 |
$12K |
| 92250 |
|
379 |
374 |
$11K |
| 94010 |
|
392 |
378 |
$9K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
764 |
710 |
$8K |
| 99497 |
|
712 |
668 |
$7K |
| 93922 |
|
167 |
146 |
$7K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
668 |
602 |
$7K |
| 99173 |
|
7,287 |
6,237 |
$7K |
| 90686 |
|
383 |
364 |
$6K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
2,208 |
1,771 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
45 |
43 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
118 |
111 |
$4K |
| 99386 |
|
40 |
40 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
364 |
315 |
$4K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
620 |
588 |
$4K |
| 90662 |
|
279 |
261 |
$4K |
| 96127 |
|
826 |
670 |
$3K |
| 99000 |
|
2,108 |
1,746 |
$3K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,151 |
1,017 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
25 |
25 |
$2K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
1,030 |
929 |
$2K |
| 90656 |
|
61 |
60 |
$2K |
| 99401 |
|
63 |
54 |
$2K |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
129 |
107 |
$2K |
| 96160 |
|
1,120 |
1,026 |
$2K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
802 |
735 |
$1K |
| 92552 |
|
45 |
44 |
$925.47 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
46 |
40 |
$829.32 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
425 |
373 |
$618.10 |
| 82043 |
|
129 |
126 |
$534.47 |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
152 |
128 |
$528.91 |
| 82570 |
|
115 |
113 |
$383.92 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
14 |
12 |
$310.50 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
212 |
170 |
$305.70 |
| 81025 |
|
45 |
43 |
$296.78 |
| G0008 |
Administration of influenza virus vaccine |
551 |
482 |
$294.84 |
| 36416 |
|
4,881 |
3,434 |
$162.31 |
| 94760 |
|
191 |
148 |
$89.34 |
| 1160F |
|
6,135 |
5,089 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
17,729 |
13,228 |
$0.00 |
| 3077F |
|
2,405 |
1,859 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
87 |
72 |
$0.00 |
| 1159F |
|
6,137 |
5,033 |
$0.00 |
| 3078F |
|
14,169 |
11,509 |
$0.00 |
| 3016F |
|
1,323 |
1,193 |
$0.00 |
| 3725F |
|
2,687 |
2,109 |
$0.00 |
| 4013F |
|
297 |
276 |
$0.00 |
| 0521F |
|
155 |
143 |
$0.00 |
| 4004F |
|
1,223 |
787 |
$0.00 |
| 4274F |
|
93 |
52 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
116 |
89 |
$0.00 |
| 3046F |
|
26 |
24 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
24 |
24 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
16 |
14 |
$0.00 |
| 2028F |
|
12 |
12 |
$0.00 |
| 1036F |
|
767 |
724 |
$0.00 |
| 3075F |
|
4,292 |
3,491 |
$0.00 |
| 3080F |
|
715 |
556 |
$0.00 |
| 1125F |
|
487 |
434 |
$0.00 |
| 3074F |
|
18,615 |
14,907 |
$0.00 |
| 4450F |
|
1,007 |
866 |
$0.00 |
| 3008F |
|
3,481 |
3,166 |
$0.00 |
| 3079F |
|
9,962 |
7,900 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
3,166 |
2,322 |
$0.00 |
| 4037F |
|
673 |
450 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
417 |
333 |
$0.00 |
| 3044F |
|
413 |
360 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
89 |
77 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
266 |
225 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
155 |
119 |
$0.00 |
| 4010F |
|
172 |
163 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
97 |
94 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
44 |
43 |
$0.00 |
| 0011A |
|
16 |
16 |
$0.00 |
| G8422 |
Bmi not documented, documentation the patient is not eligible for bmi calculation |
71 |
55 |
$0.00 |
| 3048F |
|
27 |
26 |
$0.00 |
| 82044 |
|
13 |
12 |
$0.00 |
| 1170F |
|
16 |
16 |
$0.00 |
| H0001 |
Alcohol and/or drug assessment |
78 |
68 |
$0.00 |
| 3066F |
|
20 |
15 |
$0.00 |